As previously reported, in October of 2023, the US International Trade Commission (ITC) ruled that certain pulse oximetry features of the Apple Watch infringed two of Masimo’s patents. Along with the infringement holding, the ITC issued a limited exclusion order, prohibiting the unlicensed entry of infringing Apple Watches into the United States. The Biden administration chose not to reverse the ITC’s decision, and Apple redesigned its watches in an attempt to circumvent the ban.
In January of this year, Apple submitted a Ruling Request to the US Customs and Border Protection in which it sought guidance as to whether modified versions of its watch still infringed the Masimo patents. The CBP handed down its ruling on January 12, holding that the newly modified watches did not infringe. Details of the watch re-design remained confidential, but a recently redacted version of the CBP’s ruling sheds light on how the re-design circumvents the ITC’s exclusion order. Specifically, a software change “prevent[s] the watch from engaging in any pulse oximetry functionality or measurement, (ii) prevent[s] the user from enabling any pulse oximetry functionality or measurement, including Blood Oxygen feature measurements or background measurements, and (iii) display[s] a screen indicating that the Blood Oxygen feature is unavailable[.]”
Written by Tanner Murphy
Associate, Caldwell
You may also like…
Legal dispute redefining COVID-19 vaccine patents and future of mRNA tech
The race for a COVID-19 vaccine in 2020 was a global effort, but the aftermath has seen a bitter legal battle erupt...
Delhi High Court awards Ericsson $29 million in SEP case
On 28 March 2024, the Delhi High Court concluded a decade-long litigation between Telefonaktiebolaget LM...
Celebrating World IP Day: thoughts from our Editorial Board
As World Intellectual Property Day approaches on 26 April, we asked our Editorial Board their thoughts on this year's...
Contact us to write for out Newsletter